HVAX Technologies Ltd
Established in 2010, HVAX Technologies Limited provides turnkey engineering, procurement, and execution of controlled environment and cleanroom infrastructure, design, engineering, and consulting services to pharmaceutical and healthcare companies.[1]
- Market Cap ₹ 196 Cr.
- Current Price ₹ 705
- High / Low ₹ 961 / 585
- Stock P/E 13.7
- Book Value ₹ 311
- Dividend Yield 0.00 %
- ROCE 19.7 %
- ROE 18.1 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 31.3% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Earnings include an other income of Rs.7.06 Cr.
- Company has high debtors of 193 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 44 | 61 | 68 | 96 | 106 | 131 | 160 | |
| 41 | 55 | 61 | 87 | 93 | 112 | 144 | |
| Operating Profit | 3 | 5 | 7 | 9 | 13 | 19 | 16 |
| OPM % | 7% | 9% | 10% | 9% | 12% | 14% | 10% |
| 1 | 1 | 1 | 0 | 1 | 0 | 7 | |
| Interest | 1 | 1 | 1 | 1 | 2 | 2 | 3 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 2 | 1 |
| Profit before tax | 3 | 5 | 6 | 7 | 11 | 15 | 19 |
| Tax % | 25% | 29% | 25% | 26% | 25% | 26% | 25% |
| 2 | 4 | 4 | 5 | 9 | 11 | 14 | |
| EPS in Rs | 30.96 | 60.30 | 67.76 | 84.29 | 125.00 | 39.76 | 51.50 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 19% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 31% |
| 3 Years: | 40% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 24% |
| 3 Years: | 22% |
| Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.62 | 0.62 | 0.62 | 0.62 | 0.68 | 3 | 3 |
| Reserves | 5 | 7 | 11 | 17 | 30 | 69 | 84 |
| 11 | 7 | 10 | 17 | 24 | 28 | 40 | |
| 11 | 22 | 32 | 44 | 8 | 22 | 25 | |
| Total Liabilities | 28 | 37 | 54 | 78 | 64 | 122 | 151 |
| 7 | 10 | 8 | 7 | 9 | 8 | 7 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| 20 | 26 | 45 | 70 | 54 | 114 | 143 | |
| Total Assets | 28 | 37 | 54 | 78 | 64 | 122 | 151 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 2 | 8 | -1 | -4 | -12 | -22 | -14 | |
| -1 | -4 | 2 | -0 | -2 | 0 | -1 | |
| -1 | -4 | 2 | 6 | 10 | 31 | 9 | |
| Net Cash Flow | 0 | -1 | 3 | 2 | -4 | 10 | -6 |
| Free Cash Flow | 2 | 4 | 0 | -4 | -15 | -22 | -14 |
| CFO/OP | 80% | 169% | 9% | -21% | -71% | -102% | -54% |
Ratios
Standalone / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 98 | 106 | 124 | 86 | 199 | 193 |
| Inventory Days | 26 | 24 | 130 | 114 | 109 | 95 | 144 |
| Days Payable | 92 | 77 | 74 | 53 | 32 | 72 | 72 |
| Cash Conversion Cycle | 25 | 45 | 162 | 184 | 162 | 222 | 265 |
| Working Capital Days | 7 | -8 | 1 | 10 | 67 | 146 | 165 |
| ROCE % | 36% | 32% | 27% | 28% | 22% | 20% |
Insights
In beta| Mar 2010 | Mar 2012 | Mar 2016 | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Number of Countries Served Count |
|
||||||
| International Revenue Share % |
|||||||
| Cumulative Projects Executed Count |
|||||||
| Number of Professionals Count |
|||||||
| Pharmaceutical Sector Revenue Share % |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Trading Window
- HVAX Technologies Limited has informed regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
-
Shareholders meeting
- HVAX Technologies Limited has informed regarding voting results of Annual General Meeting held on September 25, 2025
-
Shareholders meeting
- No announcement content available beyond digital signatures.
-
Outcome of Board Meeting
- HVAX Technologies Limited has informed regarding Outcome of Board Meeting held on August 24, 2026 for Book Closure Intimation
-
Record Date
- Record date for the purpose of Annual General Meeting is 17-Sep-2026.
Annual reports
-
Annual Report 2026
from nse
-
Annual Report 2025
from nse
Concalls
-
Nov 2025Transcript
-
Sep 2025PPT
-
May 2025Transcript REC
Business Profile[1] The company supplies a range of products manufactured by third parties, including cleanroom wall and ceiling panels, covings, riser panels, cleanroom doors, flooring systems, pass boxes, air showers, LT/HT electrical panels, prefabricated galvanized iron (GI) ducts, air handling units, chillers, Building Management Systems (BMS) equipment, and utility generation and distribution equipment.